Expert Highlights Avelumab Trial and Future of Immunotherapy in Head and Neck Cancer – OncLive
OncLive |
Expert Highlights Avelumab Trial and Future of Immunotherapy in Head and Neck Cancer
OncLive Investigators are aiming to measure the impact of immunotherapy as an addition to standard chemotherapy plus radiation therapy in patients with locally advanced squamous cell carcinoma of the head and neck in the phase III JAVELIN HEAD AND NECK … |
